JD BioWorks Research Resources
Research Library
Source-conscious guides to analytical methods, documentation, compound literature, regulatory developments, and evidence interpretation.
Browse articles by month, topic, or compound
Filtered Research
7 articles
GLOW Research Blend: Analytical Identity, Composition, and Study Limits
An evidence-focused guide to GLOW research blend composition, lot-specific HPLC identity, 99.65% purity, measured component content, and limits of interpreting a three-peptide mixture.
Read article
What Is TFA in Synthetic Peptides—and Why Is It on a COA?
Learn how TFA and peptide counterions affect material composition—and why HPLC purity, peptide content, and total vial mass are different measurements.
Read article
How to Read a Multi-Peptide Blend COA: KLOW 80 mg
A field-by-field guide to the KLOW 80 mg lot 2026-002 Certificate of Analysis, including HPLC purity, identity, component quantitation, net blend content, terminology, and report limitations.
Read article
The FDA Received 990 Reports About Compounded Semaglutide—But Social Media Is Reading the Number Wrong
FDA received 990 adverse-event reports associated with compounded semaglutide. Learn what the number shows—and why it does not prove causation or risk.
Read article
How Should Lyophilized Research Peptides Be Stored?
Learn how temperature, moisture, light, oxygen, and freeze-thaw cycles affect lyophilized research peptides—and why storage must be peptide-specific.
Read article
FDA Generic Peptide Guidance 2026: What Changed?
An overview of FDA's July 2026 revised draft peptide guidances and what they mean for generic drug development.
Read article
FDA Peptide Compounding Vote: What It Actually Means
A guide to the July 2026 peptide-compounding advisory votes and the difference between committee recommendations and FDA approval.
Read articleRESEARCH RESOURCE PATHWAY
Compound research evidence library
Browse research-only literature overviews organized by exact compound name. Each page separates reported findings from analytical identity and evidence limitations.
BPC-157 research evidence
A source-conscious overview of preclinical evidence and study limitations.
GHK-Cu research evidence
Research context for GHK-Cu, terminology, methods, and study limitations.
KPV research evidence
Research context, sequence identity, documentation, and evidence limitations.
MOTS-C research evidence
Research context for a mitochondrial-derived peptide and its documentation needs.
PT-141 research evidence
A research-only review of nomenclature, identity, literature, and limitations.
Selank research evidence
Research context, peptide identity, sourcing records, and evidence limits.
TB-500 research evidence
Clarify nomenclature, sequence claims, laboratory identity, and source limitations.
Tesamorelin research evidence
Research context, identity documentation, analytical methods, and evidence limits.
RESEARCH RESOURCE PATHWAY
Research and editorial standards
See how sources, corrections, and document revisions are handled.
Scientific sourcing and editorial standards
How JD BioWorks selects sources, distinguishes evidence levels, and updates research content.
Corrections and document revision policy
How factual corrections, material updates, and superseded records are handled.
START WITH THE RESEARCH QUESTION